Correspondence 0001493152-23-001500 from Qilun Group Inc. (QLUNF) (CIK 0001951378) (QLUNF)
Qilun Group Inc. (QLUNF) (CIK 0001951378)
Date: Jan. 13, 2023 · CIK: 0001951378 · Accession: 0001493152-23-001500
AI Filing Summary & Sentiment
Referenced dates: December 1, 2022
Show Raw Text
CORRESP
1
filename1.htm
Mason Allen
Of Counsel
mallen@cronelawgroup.com
VIA
EDGAR
January
13, 2023
THE
UNITED STATES SECURITIES
AND
EXCHANGE COMMISSION
Washington,
D.C. 20549
Attn:
Aamira
Chaudhry
Rufus
Decker
Re:
Qilun
Group Inc.
Draft
Registration Statement on Form F-1
Filed
November 4, 2022
CIK
No.: 0001951378
Dear
Ms. Chaudhry and Mr. Decker:
We
write on behalf of Qilun Group Inc. (the “Company”) in response to comments by the United States Securities and Exchange
Commission (the “Commission”) in its letter dated December 1, 2022, commenting on the Company’s Draft Registration
Statement on Form F-1 filed November 4, 2022 (the “Registration Statement”).
Titling
and paragraph numbering of the comments listed below corresponds to the titling and numbering used in the Commission’s comment
letter.
Draft
Registration Statement on Form F-1
Cover
Page
1. Please
refer to the prospectus cover page. We note your ordinary shares are not listed or quoted
on an existing public trading market. Please note that an at-the-market resale offering under
Rule 415 is not available for registrants with no existing public trading market. Accordingly,
please revise to clarify that the selling stockholders will sell at a fixed price until your
ordinary shares are listed or quoted on an existing public trading market, such as the OTCQB,
OTCQX or OTCBB, and thereafter at prevailing market prices or privately negotiated prices.
Please also disclose the fixed price and clarify in one of the first paragraphs that the
company currently has no existing public trading market and whether the offering is contingent
upon obtaining a listing or quotation on an existing public trading market.
Response:
In response to this comment, the Company has amended the Registration Statement cover page to state that there is currently no public
trading market, that the offering is contingent on obtaining a listing or quotation on an existing public market, and that the selling
stockholders will sell at a fixed price of $0.20 per share until the ordinary shares are listed or quoted on an existing public trading
market, and thereafter at prevailing market prices or privately negotiated prices.
2. Please
revise the seventh paragraph of the prospectus cover page to capture the risk that Chinese
regulatory authorities could change the rules and regulations regarding foreign ownership
in the industry in which you operate.
Response:
In response to this comment, the Company has amended the Registration Statement to state that Chinese regulatory authorities could change
the rules and regulations regarding foreign ownership in the industries in which we operate.
3. Please
revise the prospectus cover page to clarify that the legal and operational risks associated
with operating in China also apply to operations in Hong Kong and Macau.
Response:
In response to this comment, the Company has amened the Registration Statement to state that the legal, regulatory, operating and investment
risks applicable to our operations in China also apply to operations in the special administrative regions of Hong Kong and Macau.
4. We
note your disclosure on pages 4 and 18 that all of your operations are in China. However,
you also state at several points in the prospectus that you have an operating subsidiary
in Hong Kong. Please clarify the geographic scope of your operations and make conforming
disclosures accordingly.
Response:
In response to this comment, the Company has amened the cited disclosure throughout the Registration Statement to refer to operating
subsidiaries in China and to clarify that operations have not begun to date with respect to the Company’s Hong Kong subsidiary.
5. Provide
a description of how cash is transferred through your organization and disclose your intentions
to distribute earnings. State whether any transfers, dividends, or distributions have been
made to date between the holding company and its subsidiaries, or to investors, and quantify
the amounts where applicable. Provide cross-references to the condensed consolidating schedule
and the consolidated financial statements.
Response:
In response to this comment, the Company advises the Staff that the Company does not have a specific cash transfer policy or mechanism
among subsidiaries. The cash transfers made to date among subsidiaries include:
● Shenzhen
Houhaitang Culture Communication Co., Ltd. loaned $131,746 to Qilun Culture Development (Shenzhen)
Co., Ltd.;
● Shenzhen
Houhaitang Culture Communication Co., Ltd. sold products with amount of $71,121 to Qilun
Culture Development (Shenzhen) Co., Ltd.; and
● Qilun
Culture Development (Shenzhen) Co., Ltd. made payment of $27,899 on behalf of Qilun Enterprise
Management Consultant (Shenzhen) Co., Ltd.
The
noted three transfers have been cleared out as of the filling date and there are no remaining balances. The cash transfers were made
occasionally at the discretion of management and were not routine.
There
have been no transfers, dividends or distributions made to date between the holding company and its subsidiaries or to investors. The
Company has no intentions to distribute earnings now and in the foreseeable future.
6. Please
amend your disclosure here and in the summary risk factors and risk factors sections to state
that, to the extent cash in the business is in the PRC or Hong Kong or a PRC or Hong Kong
entity, the funds may not be available to fund operations or for other use outside of the
PRC/Hong Kong due to interventions in or the imposition of restrictions and limitations on
the ability of you or your subsidiaries by the PRC government to transfer cash. On the prospectus
cover page, provide cross-references to these other discussions.
Response:
In response to this comment, the Company has amended the Registration Statement risk factor entitled “We may rely on dividends
and other distributions on equity paid by the operating entities to fund any cash and financing requirements we may have, and any interventions
in or the imposition of restrictions and limitations on the ability of our company or the operating entities by the PRC government to
transfer cash or assets could have a material and adverse effect on our business.” to state that, “[t]o the extent cash in
the business is in accounts located in the PRC or Hong Kong, or held at a PRC or Hong Kong operating entity, the cash may not be available
to fund operations or for other use outside of the PRC or Hong Kong due to interventions in or the imposition of restrictions and limitations
by the PRC government on the ability of you or your subsidiaries to transfer cash outside of the PRC or Hong Kong.” The Company
has also amended the Registration Statement to cross-reference this risk factor on the cover page.
7. Please
revise the prospectus cover page to include the Commission Legend required by Item 501(b)(7)
of Regulation S-K.
Response:
In response to this comment, the Company has amended the Registration Statement to include the Item 501(b)(7) of Regulation S-K legend
on the cover page.
8. Please
revise the prospectus cover page to include the date of prospectus. Refer to Item 501(b)(9)
of Regulation S-K.
Response:
In response to this comment, the Company has amended the Registration Statement to include the date of the prospectus on the cover page.
Our
Products and Services, page 1
9. We
note your disclosure on pages 1 and 49 that you sell books published by third-party publishers
to retail customers. To the extent your business is materially dependent on such third-party
publishers, please identify such third-party publishers and include risk factor disclosure
to address your reliance on such third-party publishers.
Response:
In response to this comment, the Company respectfully advises the Staff that sales from third-party publishers constitute less than 10%
of annual revenue and is not a material component of the Company’s operations or business strategy. The Company has amended the
Registration Statement on page 49 to reflect such details.
10. Please
revise to disclose each permission or approval that you or your subsidiaries are required
to obtain from Chinese authorities to operate your business and to offer the securities being
registered to foreign investors. State whether you or your subsidiaries are covered by permissions
requirements from the China Securities Regulatory Commission (CSRC), Cyberspace Administration
of China (CAC) or any other governmental agency that is required to approve your operations,
and state affirmatively whether you have received all requisite permissions or approvals
and whether any permissions or approvals have been denied. Please also describe the consequences
to you and your investors if you or your subsidiaries: (i) do not receive or maintain such
permissions or approvals, (ii) inadvertently conclude that such permissions or approvals
are not required, or (iii) applicable laws, regulations, or interpretations change and you
are required to obtain such permissions or approvals in the future. To the extent you are
relaying on an opinion of counsel, then counsel should be named and a consent of counsel
filed as an exhibit. Lastly, please revise the permissions and approvals disclosures on the
prospectus cover page to align with the above guidance. In this regard, we note the disclosure
is presented from the passive perspective versus affirmatively addressing that the company
has received all requisite permissions and approvals.
Response:
In response to this comment, the Company respectfully advises the Staff that, according to the Company’s PRC legal counsel, DeHeng
Law Offices (Shenzhen), as of the date of the Registration Statement, our PRC subsidiaries have received from PRC authorities all requisite
licenses, permissions or approvals needed to engage in the businesses currently conducted in China and neither the Company nor the operating
entities have been subject to any investigation, or received any notice, warning, or sanction from the China Securities Regulatory Commission
(the “CSRC”), the Cyberspace Administration of China (the “CAC”), or other applicable government authorities
related to the proposed offering. The Company has amended the Registration Statement to reflect the above-noted disclosure.
Our
Strengths, page 2
11. Please
disclose the basis for your statement here and on page 50 that you have formed a “large
and loyal fan community” or state that it is management’s belief.
Response:
In response to this comment, the Company has amended the Registration Statement to state that “formed what we believe to be a sizeable
and loyal fan community.”
Risk
Factor Summary, page 3
12. Please
revise your disclosure to ensure that each summary risk factor in the “Risks Related
to Doing Business in China” section has a cross-reference to the relevant individual
detailed risk factor including the specific heading and page number.
Response:
In response to this comment, the Company has amended the Registration Statement to revise each summary risk factor in the “Risks
Related to Doing Business in China and Hong Kong” section to include a cross-reference to the relevant individual detailed risk
factor including the specific heading and page number.
Cash
Transfers and Dividend Distributions, page 6
13. Quantify
any cash flows and transfers of other assets by type that have occurred between the holding
company and its subsidiaries, and direction of transfer. Additionally, provide cross-references
to the condensed consolidating schedule and the consolidated financial statements.
Response:
In response to this comment, the Company advises the Staff that the Company has not made any cash transfers or asset transfers between
its subsidiaries and the Company (e.g., the Cayman Islands registrant) and does not anticipate any such transfers for the foreseeable
future.
The
Offering, page 8
14. We
note your disclosure here that you intend to apply to quote your securities on the OTCQB.
However, you state on the prospectus cover page that you intend to seek quotation of your
shares on the OTC Markets, OTCQX, or OTCQB Venture. Please revise your disclosures to consistently
reflect which OTC market you wish to seek quotation on.
Response:
In response to this comment, the Company has amended the Registration Statement to clarify, in each instance, that it intends to apply
its securities to be quoted on the OTCQB.
“The
ongoing global coronavirus COVID-19 outbreak had caused . . .”, page 14
15. Please
expand your disclosure to discuss the material effects that COVID-19 has had on the demand
for your products and operating results. Specifically, please revise these sect